Quote #-51139-catalog #-S12450-fetal bovine serum-optima-lot #-H14120
Ended Awarded
- Contract number
- 75N91018F00002
- Awardee
-
Atlanta Biologicals, Inc. UEI ULFTKRGFBBA5 Part of Bio-Techne Corporation
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $8,857
Award facts
- Contract value 100% obligated
- $8,857.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Flowery Branch, GA, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a Blanket Purchase Agreement (BPA) call to Atlanta Biologicals, Inc., a subsidiary of Bio-Techne Corporation, for the supply of Fetal Bovine Serum (FBS) Optima under Quote #51139. This firm fixed-price contract, with a ceiling value of $8,857.30, was executed on June 27, 2018, with an ultimate completion date of July 26, 2018. The contract was fulfilled at the vendor's facility in Flowery Branch, Georgia, and was not designated as a set-aside contract. Fetal bovine serum is a critical reagent widely used in cell culture and biomedical research applications, making it an essential supply item for the National Cancer Institute's research and diagnostic operations.
Bio-Techne Corporation, through its Atlanta Biologicals subsidiary, is a leading provider of life sciences tools and bioactive reagents serving the research and bioprocessing markets. The company's extensive portfolio of specialized research products, including proteins, antibodies, immunoassays, and other reagents, has positioned it as a valued supplier to multiple federal agencies including the National Institutes of Health, Department of Veterans Affairs, and Department of Defense. This BPA call represents a routine procurement of a commodity research supply that supports the National Cancer Institute's ongoing cancer research and diagnostic initiatives across its laboratory and clinical operations.
Quick answers
Who was awarded contract 75N91018F00002?
75N91018F00002 was awarded to Atlanta Biologicals, Inc. by National Cancer Institute (National Institutes of Health) on June 27, 2018.
How much is contract 75N91018F00002 worth?
The government has obligated $8,857 on 75N91018F00002.
Is contract 75N91018F00002 an order under another contract?
Yes. 75N91018F00002 is a BPA call under HHSN263201600020B, a blanket purchase agreement.
Was contract 75N91018F00002 competed?
The extent of competition for 75N91018F00002 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award